Effects of hallucinogenic drugs:
Clinical profile of patient who had taken them:
Effects of alcohol:
Pain is described as an unpleasant feeling of a sensation in the body and it can be as a result of the stimulation of the nociceptors (pain receptors) located in varies places of the body. These nociceptors are very sensitive to temperature, mechanical damage and dissolved chemicals released from injured cells and is thus these factors are seen as the “stimuli” that would cause the stimulation of the nociceptors which does lead to the pain sensation felt. This sensation can last from up to a few hours to months (that can last or return on several occasions).
People also tend to describe the painful sensation as burning, stinging, pinching or sharp stab depending on the localisation of the painful sensation, it can either be localized or more generalized where it affects more areas of the body.
Pain tolerance is seen as the maximum pain level an individual can endure and it does differ from person to person as some people may have a high pain tolerance and will not be so sensitive to the painful sensations, whereas other people may have a low pain tolerance and will there be more sensitive to the painful sensation.
To manage your pain sufficiently, treatment is available to reduce pain that can provide minimal side effects and is there to improve a patients overall functioning. Depending on the severity of the pain or how injured a patient may will determine whether around the clock medical treatment would be needed, thus if pain is superficial like headache there is no need to to refer patient but if the patient has pain due to injuries they must be referred to a medical practitioner
Using your textbooks, draw up a classification of the drugs that are used as antidepressants.
SSRI’s |
SNRI’s |
TCA’s |
5-HT antagonist |
Tetracyclic and Unicyclic |
MOAI |
NARI |
Fluoxetine Sertraline Citalopram Paroxetine Escitalopram |
Venlafaxine Duloxetine Desvenlafaxine |
Tertiary amine:
Secondary amine
|
Trazodone Nefazodone Vortioxetine
|
Bupropion Mirtazapine Amoxapine Maprotiline
|
Phenelzine Isocarboxazid Tranylcypromine Selegiline Moclobemide
|
Reboxetine |
All of these drugs promote monoamine activity by increasing NA and serotonin levels at the central synapse, by either re-uptake inhibition, degradation inhibition or the blockage of the presynaptic alpha 2 receptor.
The onset is very slow and can take up to 6-8 weeks for effects to be seen due to the action that of the anti-depressants that still needs to be altered in the brain.
Efficacy
TAD: needs to be titrated to the minimum effective dose whereas SSRI’s can be started on the full dose. All these drugs does however take 6-8 weeks for effects to be seen.
Side effects
TAD: sedation, tremors, insomnia, disturbed vision, dry mouth, urinary retention, confusion, orthostatic hypotension, dysrhythmias convulsions, weight gain and sexual dysfunction.
SSRI: Insomnia, tremors, GIT disturbances, headache, ↓ libido, sexual dysfunction, anxiety (acute), EPS, withdrawal syndrome. ↓ appetite, non-sedating, acute increases 5-HT synaptic activity = acute anxiety, later 5-HT reduces again.
Safety
TAD: Not safe in overdose but it is commonly the drug used for suicide. It causes lethal ventricular arrythmias and fibrillation and seizures.
SSRI: it is very safe with regards to overdose and this drug is better tolerable.
It blocks the action of alpha 2, 5-HT2A, 5-HT2c and 5-HT3 receptors. It also blocks histamine 1 and alpha 1 and causes the indirect stimulation of 5-HT1A
Blocks both 5-HT - and NA re-uptake, more potent for 5- HT than for NA. Moderately selective blockade of SERT and NET..
Antagonist: 5-HT2C
Agonist: Melatonergic R’s – MT1 & MT2. and NA release.
The MOA is mediated by Li+. Lithium inhibits 2 signal transduction pathways where it suppresses IP3 and glycogen synthase kinase-3. It influences IP3 and DAG 2nd messenger system by decreasing various enzymes which are important for conversion and re-circulation of membrane phosphoinositide. IP3 and DAG are important in monoamine and cholinergic neurotransmission.
It has a narrow therapeutic index of 0.5-1.5mM; >2mM = toxic
Lithium is used in monotheraphy for prophylaxis of manic and hypomanic episodes and for treatment of acute mania.
And in combination therapy it is used treatment of resistant depression and aggressive behaviour.
When used in combination with a diuretic, NSAID, ACE I and fluoxetine it increases lithium levels and leads to toxicity.
In combination with caffeine, it increases renal excretion of lithium
And in combination with a typical APs it worsens EPS.
Tremors, sedation, ataxia, aphasia, muscle weakness, fatigue, polydipsia, polyuria, nocturia, nephrogenic diabetes insipidus, thyroid enlargement, leucocytosis, edema weight gain, acne, alopecia, sexual dysfunction.
Category D drug. The use of lithium during lactation is not encouraged.
Bipolar disorder, Schizoaffective disorder, Major depression
Ms B. Polar (21 years, 60 kg) is a student and used the following medication for the past two months:
Camcolith 600mg bd. The plasma levels after two weeks were 0.8mmol/l. She sustained a muscle injury and has been using Indocid® 75mg nocte for the past 10 days. On questioning she reveals that “she had picked up a lot of weight” and is now using some of her mother’s “water pills” in the hope of losing a few of the extra kilos. However, she complains of fatigue, that she has difficulty in keeping her eyes open in class, remains thirsty and constantly feels shaky and nauseous
The NSAID she is currently taking has an interaction with the lithium treatment that she is taking. NSAIDS are known to cause increase levels of lithium making it toxic thus it explains the side effects she has been experiencing like. I would suggest that she replaces the medication she is taking for her muscle injury with something like Cyclobenzaprine which is an antispasmodic or paracetamol to help relieve the pain. I would also suggest to her to try physical activities to try and reduce the weight she has been gaining.
There are 3 sub-families which is primarily based on the side chain:
Aliphatic and piperidine compounds:
Piperazine compounds:
The D2 receptors in the mesolimbic pathway.
Atypical drugs have a higher affinity for 5-HT2A receptor thus they block more serotonergic receptors than D2 receptors and it also blocks M1, H1 receptors, whereas typical drugs only block D2 receptors in the mesolimbic pathway.
Benzamides block both D2 and D3 receptors but the risk of EPS are reduced due to the localisation of D3 receptors in the limbic area.
Aliphatic compound also tends to have a lower potency thus have less EPS.
Extrapyramidal side effects are known to be caused by the blockade of D2 receptors in the nigrostriatal pathway, therefore drugs that block D2 receptors cause EPS.
Drugs known to cause EPS is the piperazine derivatives due to their high potency thus extensively blocking D2 receptors.
Autonomic side effects are caused by the blockage of alpha and cholinergic (muscarinic) receptors in the sympathetic and parasympathetic nervous systems
Drugs that increase dopamine activity thus Dopamine agonist like Pramipexole and drugs that would decrease the cholinergic levels to restore the imbalance implicated by this disease, thus anticholinergic drugs.
Amantadine is a metaffiniod potentiator of dopamine which means that it will increase dopamine activity by increasing dopamine release, increasing the synthesis of dopamine, and blocking the reuptake of dopamine.
It is however classified as a NMDA antagonist; thus, it has anti-dyskinetic properties.
It also has the ability to act as an adenosine A2a antagonist, contributing to antiviral effects.
This broad mechanism of action gives amantadine the ability to improve bradykinesia, tremors, and rigidity, associated with parkinsonism.
Unfortunately, this drug only works for a few weeks.
MOA B inhibitors (Rasagiline and Selegiline): Inhibits MOA which is the enzyme responsible for the metabolism of dopamine. Therefore, increasing dopamine levels.
COMT inhibitor (Entacapone): Extends the duration of action of l-dopa by decreasing peripheral metabolism and increasing its bioavailability.
Ergot derivatives: Bromocriptine
Non-ergot derivatives: Ropinirole and Pramipexole
Pramipexole – direct agonist on D3 receptors
Ropinirole- D2 agonist
Bromocriptine – Partial agonist on D2
Selegiline and Rasagiline has been said to have neuroprotective properties by preventing the metabolism of dopamine it ensures that the dopamine neurons are stimulated.
It prevents the metabolism of dopamine thus increasing the dopamine levels and ensuring that the dopamine neurons are stimulated continuously.
COMT metabolises L-dopa to 3OMD. Where increased levels of 3OMD has a weak therapeutic response with L-dopa due to them competing for active transport, thus it increases the duration of action of L-dopa by decreasing peripheral metabolism and increasing it bioavailability.
It acts as Adenosine a2A antagonist. Adenosine is known to block dopamine 2 receptors thus blockade of adenosine improves dopamine 2 function.
MOA: Noval dual MOA where it increases dopamine activity by causing reversible inhibition of MAO-B. Inhibition of DA uptake decreases glutamate release.
How does the sensitivity for blockade by a LA compare regarding the following types of fibres:
(a) myelinated fibres with unmyelinated fibres; and
(b) pressure/touch nerves with the dorsal nerves that transmit pain impulses?
Make a list of the effects of LA on other tissues.
CVS: cardiac depression
CNS: sedation, lightheadedness, visual and auditory disturbances, restlessness, and CNS depression.
Skeletal muscle: it has a weak blocking action thus no clinical applications.
What is the basis for the selection of a LA?
it is chosen by the type of procedure that is done, the target tissue it is must be used for and the duration of the numbering effect.
Why are LA solutions sometimes saturated with CO2?
It buffers the local anesthetics. Reduces the pain of injection and thus a faster onset is achieved. It also raises the effective concentration of nonionized form of the local anesthetic, onset of regional block is shortened.
Which of the LA are typically used for surface anaesthesia?
Oxybuprocaine, benzocaine and cocaine
Drug |
Effects on System |
Halothane
|
Central Nervous System
Autonomic Nervous System
Cardiovascular System
Respiratory System
Musculo-skeletal
Uterus
Liver
|
Enflurane |
Central Nervous System:
Cardiovascular System
Respiratory System
|
Isoflurane |
Central Nervous System
Cardiovascular System
Respiratory System
|
Desflurane |
Central Nervous System
Cardiovascular System
Respiratory System
|
Sevoflurane |
Same effects than Desflurane. Respiratory System
|
Nitric Oxide |
Central Nervous System
Cardiovascular System
Respiratory System
|
2) Nephrotoxicity, Hematotoxicity, Malignant hyperthermia, Hepatotoxicity.
Which of the anti-epileptic drugs affect the metabolism of the Pill (oral contraceptive) and what are the implications of this? Which drugs are safe to use in combination with the Pill
Drugs that decrease the effectiveness of the pill are as follows: Phenobarbitone, phenytoin, carbamazepine, oxcarbazepine and topiramate. Due to its decreasing the effectiveness of the pill it may lead to an unwanted pregnancy.
Drugs that are safe to use in combo with the Pill: Valporate, Lamotrigine, Gabapentin, Leviteracetam and Vigabartin.
Can oral contraceptives also affect the effectivity of the anti-epileptic drugs?
Yes, oral contraceptives decrease the serum levels of anti-epileptic drugs for example, Valporate.
How does age affect the kinetics of these drugs (from neonates to old age)
Metabolism of anti-epileptic drugs are slower in neonates than in adults, but metabolism of these drugs is faster in babies and in children than adults. And due to lowered metabolic activity in geriatrics metabolism does appear to be slower in geriatrics than in adults.
In which cases is plasma blood level monitoring indicated?
it is indicated to see how well a patient’s body tolerates a drug and help a practitioner to identify if any unwanted effects are experienced with the drug. For example, in the case of Valporate and lamotrigine, as valproate deceases the metabolism of lamotrigine which leads to the increased levels of lamotrigine in the blood and in its turn can cause toxicity.